Beaumont Financial Partners, LLC Abiomed Inc Transaction History

Beaumont Financial Partners, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Nov 06, 2019	SELL	$175.89 - $279.23 $150,385 - $238,741	-855 Closed	0 $0
Q2 2019 Aug 06, 2019	SELL	$250.96 - $284.94 $79,052 - $89,756	-315 Reduced 26.92%	855 $223,000
Q1 2019 May 06, 2019	SELL	$276.39 - $362.25 $103,646 - $135,843	-375 Reduced 24.27%	1,170 $334,000
Q2 2018 Aug 06, 2018	SELL	$278.07 - $446.21 $263,332 - $422,560	-947 Reduced 38.0%	1,545 $632,000
Q1 2018 May 11, 2018	SELL	$192.49 - $295.85 $11,164 - $17,159	-58 Reduced 2.27%	2,492 $725,000
Q4 2017 Feb 05, 2018	BUY	$168.78 - $199.74 $50,634 - $59,922	300 Added 13.33%	2,550 $478,000
Q2 2017 Aug 11, 2017	BUY	N/A	2,250	2,250 $322,000

137K

Ticker ABMD
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 45,460,900
Description
Abiomed, Inc. engages in the research, development, and sale of medical devices to assist or replace the pumping function of the failing heart. It also provides a continuum of care to heart failure patients. The company offers Impella 2.5, a percutaneous micro heart pump with integrated motor and sensors; and Impella CP, a device for use by inte...

Get notified when there are updates to the investment portfolio of Beaumont Financial Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Beaumont Financial Partners, LLC with notifications on news.